Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Rev Hematol. 2013 Oct;6(5):485-7. doi: 10.1586/17474086.2013.827884. Epub 2013 Oct 2.

Multikinase inhibitors for treating high-risk myelodysplastic syndromes: can this be brought into clinical practice?

Author information

1
University of Maryland Greenebaum Cancer Center, Baltimore, 22 S. Greene Street, S9D04B, Baltimore, MD 21201, USA +1 410 328 2567 +1 410 328 6896 vduong@umm.edu.
PMID:
24083503
DOI:
10.1586/17474086.2013.827884
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center